The ONE Forum

Annual conference hosted by the NMDP/Be The Match 

Thanks to attendees’ outstanding participation and engagement, The ONE Forum 2021 was a resounding success. Continue your journey of learning and innovation by viewing the following on-demand sessions at your convenience. 

Save the date for The ONE Forum®️ 2022 on Friday, Nov. 4 and Saturday, Nov. 5, in Minneapolis. 
Join us in-person or virtually
Register here

Available 2021 on-demand sessions

Cryopreservation Beyond the Pandemic - Current State of the Science and Practical Application
In this ultra-cool session, we will share an update on current trends around using cryopreservation to support unrelated transplant as well as provide a brief review of the most recent studies evaluating the use of cryopreserved allogeneic grafts.

Data2Knowledge4Patients: Clinical Decisioning Tools Under Development
This session focuses on initiatives and tools the CIBMTR® (Center for International Blood and Marrow Transplant Research®) and National Marrow Donor Program® (NMDP)/Be The Match® have underway to address this challenge.

Diversity in Clinical Trials  
This session will review disparities in clinical research as well as provide ways to increase clinical trial enrollment amongst underrepresented communities.

Expanding Transplant Access to Diverse Populations Using Mismatched Unrelated Donor (MMUD) Therapies  
This session will describe how recent research with mismatched unrelated donor (MMUD) therapies aims to expand access to transplant across diverse patient populations.

Haplo vs MUD: An Apples to Apples Comparison and What This Could Mean for Your Patients  
This session will take a deep dive into the CIBMTR GS18-01 study findings, focusing on real life application in how it relates to graft source selection and patient treatment plans.

Is Age Just a Number: How Donor and Patient Age Can Both Impact Outcomes
In this session, you will learn how age impacts patient outcomes—when it may be appropriate to consider older patients for HCT and why you should leverage younger donors. New data showing the advantage for HCT over non-HCT therapies in older MDS patients is also shared.

Novel Allogeneic Cellular Therapies: Predictions for the Future
In this session, a panel of industry and clinical experts will explore the promise and risks associated with allogeneic cell therapy approaches.

Same Dog, New Tricks: How Be The Match BioTherapies is Transforming Cellular Therapy in Transplant Centers
In this session, learn how the National Marrow Donor Program® (NMDP)/Be The Match® is supporting cell therapy in transplant centers today and into the future.

State of the Science: Navigating HLA-Matched and Mismatched Graft Sources
This session includes an in-depth discussion on the current science supporting the selection of HLA-matched and mismatched donors. Experts from across the transplant and cell therapy community will explore recent research into the identification of permissive matches.

Year 2 of HCT and COVID-19: Considerations for Navigating HCT During the Ongoing Pandemic
This session will look at clinical and logistical considerations for transplant and cell therapy programs in the context of the second year of the global COVID-19 pandemic.